Agoura Hills, CA, United States of America

Vuong Trieu

This inventor holds 35 USPTO granted patents and 71 published patent applications, plus 14 CIPO patents and 18 EPO patents, primarily in Cancer Treatment. Top assignees: Abraxis Bioscience, LLC, Autotelic, LLC, Nantbioscience, Inc.. Active years: 2008-2018.

USPTO Granted Patents = 35 

% Patents Active = 91.4

 

 

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 842(Granted Patents)


Location History:

  • Calabasas, CA (US) (2008 - 2015)
  • Agoura Hills, CA (US) (2013 - 2018)

Company Filing History:


Years Active: 2008-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
SPARC Binding
Pancreatic Cancer
Nanoparticle Delivery
Pharmacological Agents
Affinity Reagents
Personalized Medicine
Antibody-Based
Hypertension Treatment
Chemotherapy Response
Dicarbonyl Derivatives
Melatonin Derivatives
Propofol Analogs
35 patents (USPTO):Explore Patents

Title: Innovator Profile: Vuong Trieu

Introduction: Vuong Trieu is a prominent inventor based in Agoura Hills, California, recognized for his significant contributions to medical technology and pharmacology. With an impressive portfolio of 35 patents, Trieu has made a notable impact on advancements in healthcare solutions.

Latest Patents: Among his latest innovations is the patent for SPARC binding single-chain variable fragments (ScFvs), which provides compositions underscoring the application of these fragments in medical treatments. Another significant patent focuses on a composition, device, and method for detecting olmesartan, aimed at improving compliance in treating hypertension. This invention encompasses antibodies, fragments, and methodologies for accurately detecting and quantifying olmesartan in samples. It enhances the treatment of hypertension by monitoring patient adherence through pharmacokinetic parameters using point-of-care devices post-administration of antihypertensive drugs, such as olmesartan.

Career Highlights: Vuong Trieu's career has flourished through his roles in influential companies such as Abraxis Bioscience and Autotelic. His experiences in these organizations have been pivotal in shaping his inventive career and contributions to biomedical research.

Collaborations: Throughout his professional journey, Trieu has collaborated with notable figures in the industry, including Neil P. Desai and Patrick Soon-Shiong. These partnerships have fostered a culture of innovation, leading to groundbreaking advancements in healthcare.

Conclusion: Vuong Trieu stands out as a formidable inventor in the field of medical science, showcasing a commitment to improving patient outcomes through innovative technologies. His array of patents reflects his dedication to advancing healthcare solutions, ensuring that his contributions will continue to benefit the medical community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…